Commitment of activated T cells to secondary responsiveness is enhanced by signals mediated by cAMP-dependent protein kinase A-I

Molecular Pharmacology

Volumn 62, Issue 6, 2002, Pages 1471-1481

  Vig, Monika ^a   George, Anna ^a   Sen, Ranjan ^a,b   Durdik, Jeannine ^c   Rath, Satyajit ^a   Bal, Vineeta ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b BRANDEIS UNIVERSITY   (United States)

^c UNIVERSITY OF ARKANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CD3 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PENTOXIFYLLINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE VII; ROLIPRAM; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENYLATE CYCLASE; APOPTOSIS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; ISOENZYMES; LYMPHOCYTE ACTIVATION; PENTOXIFYLLINE; T-LYMPHOCYTES;

EID: 0036893095     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.6.1471     Document Type: Article

References (41)

1. Ahmed R and Gray D (1996) Immunological memory and protective immunity: Understanding their relation. Science (Wash DC) 272:54-60.
2. Beals CR, Sheridan CM, Turck CW, Gardner P, and Crabtree GR (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science (Wash DC) 275:1930-1934.
3. Beavo JA (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:725-748.
4. Bernard A, Lamy And L, and Alberti I (2002) The two-signal model of T-cell activation after 30 years. Transplantation 73(1 Suppl):S31-S35.
5. Brindle P, Nakajima T, and Montminy M (1995) Multiple protein kinase A-regulated events are required for transcriptional induction by cAMP. Proc Natl Acad Sci USA 92:10521-10525.
6. Bryce PJ, Dascombe MJ, and Hutchinson IV (1999) Immunomodulatory effects of pharmacological elevation of cyclic AMP in T lymphocytes proceed via a protein kinase A independent mechanism. Immunopharmacology 41:139-146.
7. Busca R, Abbe P, Mantoux F, Aberdam E, Peyssonnaux C, Eychene A, Ortonne JP, and Ballotti R (2000) Ras mediates the cAMP-dependent activation of extracellular signal-regulated (ERKs) in melanocytes. EMBO (Eur Mol Biol Organ) J 19: 2900-2910.
8. Carlson CR, Witczak O, Vossebein L, Labbe JC, Skalhegg BS, Keryer G, Herberg FW, Collas P, and Tasken K (2001) CDK1-mediated phosphorylation of the RIIalpha regulatory subunit of PKA works as a molecular switch that promotes dissociation of RIIalpha from centrosomes at mitosis. J Cell Sci 114:3243-3254.
9. Chen C, Edelstein LC, and Gelinas C (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687-2695.
10. Giembycz MA, Corrigan CJ, Seybold J, Newton R, and Barnes PJ (1996) Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: Role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol 118:1945-1958.
11. Gjertsen BT, Mellgren G, Otten A, Maronde E, Genieser HG, Jastorff B, Vintermyr OK, McKnight GS, and Doskeland SO (1995) Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J Biol Chem 270:20599-607.
12. Glavas NA, Ostenson C, Schaefer JB, Vasta V, and Beavo JA (2001) T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc Natl Acad Sci USA 98:6319-6324.
13. Gupta M, Satyaraj E, Durdik JM, Rath S, and Bal V (1997) Differential regulation of T cell activation for primary versus secondary proliferative responses. J Immunol 158:4113-4121.
14. Gupta M, George A, Sen R, Rath S, Durdik JM, and Bal V (1999) Presence of pentoxifylline during T cell priming increases clonal frequencies in secondary proliferative responses and inhibits apoptosis. J Immunol 162:689-695.
15. Herberg FW, Maleszka A, Eide T, Vossebein L, and Tasken K (2000) Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. J Mol Biol 298: 329-339.
16. Kammer GM (1998) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9:222-229.
17. Kammer GM, Boehm CA, Rudolph SA, and Schultz LA (1988) Mobility of human T lymphocyte surface molecules CD3, CD4 and CD8: Regulation by a cAMP-dependent pathway. Proc Natl Acad Sci USA 85:792-796.
18. Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, and Hong SH (2001) 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 93:33-41.
19. Laxminarayana D, Berrada A, and Kammer GM (1993) Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J Clin Invest 92:2207-2214.
20. Li L, Yee C, and Beavo JA (1999) CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science (Wash DC) 283:848-851.
21. Liou HC, Zhuang J, Tumang J, Andjelic S, Smith KA, and Liou ML (1999) c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int Immunol 11:361-371.
22. MacKenzie WM, Hoskin DW, and Blay J (1999) The adhesion of anti -CD3-activated mouse T cells to syngeneic colon adenocarcinoma cells is differentially regulated by protein tyrosine kinase-, protein kinase C- and cAMP-dependent pathways in the effector cell. Biochem Biophys Res Commun 255:460-465.
23. Manna SK, Haridas V, and Aggarwal BB (2000) Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein-1 and c-Jun N-terminal kinase. J Interferon Cytokine Res 20:725-735.
24. McHeyzer-Williams MG, and Davis MM (1995) Antigen-specific development of primary and memory T cells in vivo. Science (Wash DC) 268:106-111.
25. Michel JJ and Scott JD (2002) Akap mediated signal transduction. Annu Rev Pharmacol Toxicol 42:235-257.
26. Ramstad C, Sundvold V, Johansen HK, and Lea T (2000) cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway. Cell Signal 12:557-563.
27. Russell JH, White CL, Loh DY, and Meleedy-Rey P (1991) Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 88:2151-2155.
28. Satyaraj E, Rath S, and Bal V (1994) Induction of tolerance in freshly isolated alloreactive CD4+ T Cells by activated T cell stimulators. Eur J Immunol 24: 2457-2461.
29. Schreiber E, Matthias P, Muller MM, and Schaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419.
30. Skalhegg BS, Rasmussen AM, Tasken K, Hansson V, Jahnsen T, and Lea T (1994a) Cyclic AMP sensitive signalling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex. Scand J Immunol 40:201-208.
31. Skalhegg BS, Tasken K, Hansson V, Huitfeldt HS, Jahnsen T, and Lea T (1994b) Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science (Wash DC) 263:84-87.
32. Skalhegg BS and Tasken K (2000) Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation and subcellular localization of subunits of PKA. Front Biosci 5:D678-D693.
33. Strasser A, Grumont RJ, Stanley ML, and Gerondakis S (1999) The transcriptional regulator Rel is essential for antigen receptor-mediated stimulation of mature T cells but dispensable for positive and negative selection of thymocytes and T cell apoptosis. Eur J Immunol 29:928-935.
34. Suresh R, Vig M, Bhatia S, Goodspeed EPB, John B, Kandpal U, Srivastava S, George A, Sen R, Bal R, et al. (2002) Pentoxyphylline functions as an adjuvant in vivo to enhance T cell immune responses by inhibiting activation-induced cell death. J Immunol 169:4262-4272.
35. Swain SL (1994) Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 7:543-552.
36. Sun Y, Li L, Lau F, Beavo JA, and Clark EA (2000) Infection of CD4+ memory T cells by HIV-1 requires expression of phosphodiesterase 4. J Immunol 165:1755-1761.
37. Tasken K, Skalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, et al. (1997) Structure, function and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprotein Res 31:191-204.
38. Vang T, Torgersen KM, Sundvold V, Saxena M, Levy FO, Skalhegg BS, Hansson V, Mustelin T, and Tasken K (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 193:497-507.
39. Vijayaraghavan S, Stephens DT, Trautman K, Smith GD, Khatra B, da Cruz e Silva EF, and Greengard P (1996) Sperm motility development in the epididymis is associated with decreased glycogen synthase kinase-3 and protein phosphatase 1 activity. Biol Reprod 5:709-718.
40. Wang W, Tam WF, Hughes CC, Rath S, and Sen S (1997) c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6:165-174.
41. Zaccolo M and Pozzan T (2002) Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science (Wash DC) 295:1711-1715.